Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Key findings from a national enhanced HIV surveillance system: 2010 - 2012.
Tarasuk J, Ogunnaike-Cooke S, Archibald C, MacLean R, Bennett R, Kim J, Malloch L; I-Track Principal Investigators. Tarasuk J, et al. Among authors: archibald c. Can Commun Dis Rep. 2014 Nov 20;40(18):397-407. doi: 10.14745/ccdr.v40i18a05. eCollection 2014 Nov 20. Can Commun Dis Rep. 2014. PMID: 29769871 Free PMC article.
National trends of AIDS and HIV in Canada.
Geduld J, Archibald C. Geduld J, et al. Among authors: archibald c. Can Commun Dis Rep. 2000 Dec 1;26(23):193-201. Can Commun Dis Rep. 2000. PMID: 11131688 English, French. No abstract available.
Prevalence and determinants of HIV-1 subtypes in Canada: enhancing routinely collected information through the Canadian HIV Strain and Drug Resistance Surveillance Program.
Jayaraman GC, Gleeson T, Rekart ML, Cook D, Preiksaitis J, Sidaway F, Harmen S, Dawood M, Wood M, Ratnam S, Sandstrom P, Archibald C. Jayaraman GC, et al. Among authors: archibald c. Can Commun Dis Rep. 2003 Feb 15;29(4):29-36. Can Commun Dis Rep. 2003. PMID: 12647670 English, French. No abstract available.
A population-based approach to determine the prevalence of transmitted drug-resistant HIV among recent versus established HIV infections: results from the Canadian HIV strain and drug resistance surveillance program.
Jayaraman GC, Archibald CP, Kim J, Rekart ML, Singh AE, Harmen S, Wood M, Sandstrom P. Jayaraman GC, et al. Among authors: archibald cp. J Acquir Immune Defic Syndr. 2006 May;42(1):86-90. doi: 10.1097/01.qai.0000196666.16616.fe. J Acquir Immune Defic Syndr. 2006. PMID: 16763495
Estimates of HIV prevalence and incidence in Canada, 2005.
Boulos D, Yan P, Schanzer D, Remis RS, Archibald CP. Boulos D, et al. Among authors: archibald cp. Can Commun Dis Rep. 2006 Aug 1;32(15):165-74. Can Commun Dis Rep. 2006. PMID: 16897908 Free article. English, French. No abstract available.
Acceptability of human papillomavirus vaccination and sexual experience prior to disclosure to health care providers among men who have sex with men in Vancouver, Canada: implications for targeted vaccination programs.
Rank C, Gilbert M, Ogilvie G, Jayaraman GC, Marchand R, Trussler T, Hogg RS, Gustafson R, Wong T; ManCount Study Team. Rank C, et al. Vaccine. 2012 Aug 24;30(39):5755-60. doi: 10.1016/j.vaccine.2012.07.001. Epub 2012 Jul 15. Vaccine. 2012. PMID: 22796376
Hepatitis B surveillance in Canada: 2005-2012.
Payne E, Totten S, Laroche J, Archibald C. Payne E, et al. Among authors: archibald c. Can Commun Dis Rep. 2014 Jul 10;40(13):266-273. doi: 10.14745/ccdr.v40i13a01. eCollection 2014 Jul 10. Can Commun Dis Rep. 2014. PMID: 29769851 Free PMC article.
177 results